1. Home
  2. SOTK vs CLNN Comparison

SOTK vs CLNN Comparison

Compare SOTK & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

HOLD

Current Price

$5.30

Market Cap

73.7M

Sector

Technology

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$5.27

Market Cap

79.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOTK
CLNN
Founded
1975
2012
Country
United States
United States
Employees
N/A
79
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
73.7M
79.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
SOTK
CLNN
Price
$5.30
$5.27
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
N/A
$33.75
AVG Volume (30 Days)
43.0K
52.0K
Earning Date
05-27-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
37.50
N/A
EPS
0.05
N/A
Revenue
$20,909,315.00
N/A
Revenue This Year
$4.02
$17.64
Revenue Next Year
$10.95
$19,516.77
P/E Ratio
$108.40
N/A
Revenue Growth
1.97
N/A
52 Week Low
$3.23
$3.50
52 Week High
$6.24
$13.50

Technical Indicators

Market Signals
Indicator
SOTK
CLNN
Relative Strength Index (RSI) 53.18 44.64
Support Level $4.69 $4.53
Resistance Level $5.79 $6.61
Average True Range (ATR) 0.35 0.31
MACD 0.01 -0.00
Stochastic Oscillator 52.53 51.20

Price Performance

Historical Comparison
SOTK
CLNN

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: